India – US Trade Deal
Blogs & News
Sun Pharma, Cipla Drag NIFTY PHARMA Lower After Trump’s 100% Tariff on Branded Drugs; Generics Exempt
US–India Trade Deal: Phase-One Washington Talks Target Tariff Rollback & H-1B Fees — Latest Update
NIFTY IT Crashes: How a $100,000 Visa Fee Could Reshape Indian IT Margins and Valuations
Is It Time to Buy Infosys or Persistent? Fed Rate Cut Fuels IT Stock Optimism, Says PL Capital’s Pritesh Thakkar
India-US Trade Talks Resume in New Delhi: Tariffs, Russian Oil, and Modi’s ‘Forward-Looking’ Quote in Focus